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Objectives: HIV/AIDS prevalence in Colombia is 0,8%. Currently for the country 
is important to assess the effectiveness and impact of its practices on the health 
of its population. A health maintenance organization (HMO) with national cover-
age aims to contribute by assessing the health outcomes of its care program for 
HIV/AIDS patients, a high cost disease with great impact on HRQOL. To evaluate the 
cost-effectiveness of the care program for HIV/AIDS patients insured by a HMO in 
Colombia, comparing its results in three health care providers (HCP). MethOds: A 
Markov model in MS Excel® was built to represent the natural history of HIV/AIDS 
based on the staging of the disease given by WHO according to the CD4 lymphocytes 
level. Direct costs were included, according to the information available on HMO´s 
databases. The outcome measure were QALY’s taken from the literature. Transition 
probabilities were calculated from tracking a cohort of 884 HIV/AIDS patients over 
18 years old, from three health providers (HCP A, B and C) in 7 cities across the coun-
try, during 2011 and 2012. Time horizon was lifetime. Perspective was third payer. 
Deterministic and probabilistic sensitivity analysis were performed. Results: HCP 
C was dominated. HCP A versus HCP B ICER was USD$2.497 per life year gained and 
USD$3.674 per QALY. Annual average cost per patient by stage was: stage 1 USD$2.347, 
USD$2.281 stage 2, stage 3 USD$3.022, USD$4.103 stage 4 and USD$6.994 for stage 
5. cOnclusiOns: Given a willingness to pay 1 GDP per capita for the country, the HCP 
B is a very cost-effective option. The average annual cost of patients in stage 5 is three 
times stage 1. PRiMARy Funding sOuRce: health maintenance organization (HMO).
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Objectives: Breast magnetic resonance imaging (MRI) is a sensitive method of 
breast screening and is increasingly being used for detection of breast cancer among 
high risk young women. However, the specificity of breast MRI is relatively low and 
costs are quite high. The purpose of this study was to determine if breast MRI is 
a cost-effective approach for the detection of breast cancer among young women 
at high risk. MethOds: A Markov model was built up to compare annual breast 
cancer screening with either breast MRI or mammography among young women 
who have more than 15% lifetime risk of breast cancer. Data from published studies 
provided probabilities for the model inputs. All costs and benefits were discounted 
at 5% per year. The analysis was performed from societal perspective with results 
reported in 2013 U.S. dollars. One-way and net benefits sensitivity analyses addressed 
uncertainty in model parameters. Results: Breast MRI provided 19.38 discounted 
quality-adjusted life-years (QALYs) at a discounted cost of $37,765 while mam-
mography provided 19.14 QALYs at a cost of $23,226 over 30 years of screening. The 
incremental cost-effectiveness ratio of breast MRI compared to mammography was 
$59547/QALY. In one-way sensitivity analysis and net benefits sensitivity analysis, the 
cost-effectiveness or net benefits of MRI screening depends critically on the accuracy 
of both MRI and mammography. cOnclusiOns: Annual MRI screening of women 
who have more than 15% lifetime risk of breast cancer was found to be potentially 
cost-effective, with an ICER of $59547/QALY when compared to annual mammography 
alone. The benefits of early detection of breast cancer with MRI in this population may 
outweigh the added cost of screening and the higher risk of false positives. However, 
the cost-effectiveness of MRI screening is highly dependent on the accuracy of MRI 
and Mammography. There remains some statistical uncertainty around this result.
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Objectives: Untreated syphilis in pregnancy is associated with adverse clinical 
outcomes to the infant. In low and middle income countries in Asia, roughly one 
out of three women is not tested for syphilis during pregnancy. The objective of 
this analysis was to evaluate the cost-effectiveness, budget impact, and potential 
reduction in adverse pregnancy outcomes of antenatal syphilis screening using 
the recently introduced point of care immunochromatographic strip (ICS) test for 
11 select countries in Asia. MethOds: A previously published cost-effectiveness 
model was adapted to reflect the perspectives of the respective national health 
care systems. Clinical outcomes of infants born to syphilis-infected mothers on 
the endpoints of stillbirth, neonatal death and congenital syphilis were obtained 
from published sources. Treatment was assumed to consist of three injections of 
benzathine penicillin. Country-specific inputs included the antenatal prevalence 
of syphilis; annual number of live births; proportion of women with at least one 
antenatal care visit; per capita gross national income and estimated hourly nurse 
wages. Results: In all 11 Asian countries, syphilis screening is highly cost-effec-
tive with an weighted average cost/DALY averted of US$82 (range: US$22-US$518). 
Universal screening may reduce the annual number of stillbirths by up to 10,000, 
neonatal deaths by up to 4,000, the annual incidence of congenital syphilis by up to 
5,000 and avert up to 450,000 DALYs at an incremental annual direct medical cost of 
US$23.0 million. Due to its low screening rate of 0.1%, Indonesia accounts for almost 
50% of DALYs that could be averted. In contrast, Laos, Malaysia, and Thailand are 
close to universal screening and leave little room for improvement. cOnclusiOns: 
The use of ICS tests for antenatal syphilis screening is highly cost-effective in low 
and middle income countries in Asia. Antenatal programs should either expand or 
maintain full access to syphilis screening using the ICS test.
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obtained from published literature. Resource utilization and costs associated with 
managing vision loss and eye examination were obtained from Health PEI, Ontario 
Ministry of Health and Long-term Care, and published literature. A decision analytic 
model was used to estimate an incremental cost-effectiveness ratio (ICER). Costs 
were expressed in 2012 Canadian dollars. A series of sensitivity analyses, including 
one-way and two-way sensitivity analyses, was performed to assess the possible 
uncertainty and robustness of our findings. Results: Compared with non-insured 
eye examination, insured eye examination for PEI residents led to an annual gain of 
0.01 quality adjusted life year (QALY) and an incremental cost of $5.52 per person, 
yielding an ICER of $2,785 per QALY. Sensitivity analyses showed that cost-effective 
estimates were highly sensitive to the incidence of vision loss, rate of eye examination 
by optometrists, and utility of vision loss. Specifically, higher incidence of vision loss 
and greater rate of eye examination by optometrists offered lower cost-effectiveness 
ratios. cOnclusiOns: Insured eye examination for PEI residents was a highly cost-
effective option compared to non-insured eye examination. This intervention was 
even more cost-effective if greater proportion of PEI residents received the eye exami-
nation by optometrists and if the incidence of vision loss in PEI increased.
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Objectives: Clinic evidence shows that nephroprotection programs in patients 
with chronic kidney disease improve patient’s health, life expectancy and reduce 
hospitalizations and early deaths. In Mexico, there are few nephroprotection 
programs. The purpose of this study was to analyze a nephroprotection program 
in patients of the Mexican Institute of Social Security with chronic kidney dis-
ease aimed to improve life expectancy and to reduce hospitalizations and early 
deaths. MethOds: The study design was a cost-effectiveness analysis from the 
governmental perspective. All the costs were obtained from the Diagnosis-related 
groups that Mexican Institute of Social Security publishes. Costs were expressed 
in 2013 constant USD. A Markov model with forty eight monthly cycles was used. 
We considered five chronic kidney disease stages according to US National Kidney 
Foundation and also death stage. Parameters were obtained from other nephropro-
tection programs and also from the Mexican Institute of Social Security statistics. 
Years life gained, hospitalizations and early deaths avoided ICER were estimated 
and discounted at 5% annual rate. Univariate sensitivity analysis for costs was 
performed. Also we conducted budget impact analysis. Results: The nephro-
protection program was cost-saver for cost per year life gained (ICER= $-1,477) 
and for hospitalizations avoided (ICER= $-4,984) and cost-effective for early death 
avoided (ICER= $22,738). The program increases thirteen months life expectancy, 
reduces 50% hospitalizations and avoids 21,118 deaths in a four-year horizon. The 
hospitalizations avoided also allow increasing hospital supply in 67%. The budget 
impact analysis showed that the program could achieve savings of 42% for the 
Institute. cOnclusiOns: The nephroprotection program could improve patient’s 
health and reduce disease progression, therefore, it could be considered for imple-
mentation in the Mexican Institute of Social Security.
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Objectives: The follow-up rate among children with vision problems in our out-
reach programs has been poor (< 5%). We therefore developed the Children’s Eye 
Care Adherence Program (CECAP) for Philadelphia school children, a social worker 
(SW) intervention to address barriers to care among children with significant vision 
problems. The objective of this study was to measure CECAP’s effectiveness and cost. 
We also sought to identify barriers to care through a conceptual framework and 
geomapping software. MethOds: CECAP included SW review of records to identify 
children needing follow-up. SW phoned families to identify and resolve barriers to 
eye care and scheduled appointment. Effectiveness was defined as the percent com-
pleting ≥ 1 follow-up visit within the physician-recommended time frame. Cost was 
measured using SW time logs (converted to costs using SW wage rates + benefits) 
and additional materials (forms, postage, phone charges). Barriers were organized 
into a conceptual framework depicting 3 main themes (predisposing factors, system 
factors, and ability to pay) and mapping software to visually illustrate follow-up 
rate. Results: Of 1200 patients, 120 required follow-up ophthalmic care in 2012-
13. 71 patients were reached and completed a follow-up (59.2%); 49 patients were 
reached but did not follow-up (40.8%). SW time was ~3hrs/patient for those who 
followed up and ~2hrs/patient for those that did not. Based on the CECAP program 
total cost ($14,249) and the reimbursement payment ($6,265.66), the net cost of 
the CECAP program was $7,983.59. Predisposing factors (lack of awareness, level of 
perceived importance, conflict of commitment, lack of means of communication) 
was the primary barrier theme for patients that did not follow-up. cOnclusiOns: 
CECAP significantly improved adherence to eye care but comes at an additional 
cost. Future efforts should focus on reducing operational efficiencies (e.g., capping 
outreach attempts) and targeting CECAP based on predictors of follow-up.
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